Hypopituitarism is associated with increased morbidity and mortality (1, 2) . Hypopituitary adults are treated conventionally using thyroxine, adrenal steroid and sex hormone replacement where appropriate, but growth hormone (GH) is not usually replaced (3, 4) . Growth hormone deficiency is, however, common in pituitary disease at presentation or following treatment by surgery or radiotherapy (5) . Growth hormone is a major anabolic hormone and its role in adult life has received much attention in recent years (6, 7) . We (8) . We have observed also a relationship between circulating insulin-like growth factor I (IGF-I) concen¬ tration and the left ventricular mass and cardiac work on exercise, suggesting a physiological role for GH in the maintenance of cardiac structure and function in adults (8) . A causal relationship has been suggested between GH deficiency and the increased vascular morality and morbidity in hypopituitary adults (1, 2) , but this relation is still not clear (9) .
The aim of this study was to investigate the cardiovascular effects of replacement therapy in a large group Chromophobe adenoma 2 7 Craniopharyngioma 2 6 Cushing's disease 2 1 Other pathology0 2 1 Replacement treatment (N) (17) . In the present study, we have used established methods to assess cardiac structure and function and a high workload treadmill protocol to assess exercise tolerance before and after GH treatment. Four months of GH treatment has been shown previously to be sufficient to demonstrate the anabolic action of GH (18) . Although the GH dose in the present study was lower than in some previous studies, the mean serum IGF-I on GH increased significantly to the physiological range (and, in some cases, to the supraphysiological range). The patients in the present study were older than groups studied previously (18, 19) .
There are two principal findings in this study. Firstly 6 months of GH treatment significantly decreased the isovolumic relaxation time, reflecting an improvement in the diastolic function; secondly, exercise tolerance measured as exercise time significantly improved on GH treatment.
In experimental animals, the sizes of visceral organs, including the heart, are reduced after hypophysectomy (20) and increase with GH administration, fn acrome¬ galy, visceral organs are abnormally large (21, 22) and there is increased total body lean tissue mass (23) . However, administration of physiological amounts of GH did not increase body weight in our GH-deficient subjects, in keeping with other studies (18, (24) (25) (26) (27) . However, GH has a potent effect on body composition, with a decrease in fat and an increase in lean tissue, including muscle (18, (24) (25) (26) (27) (28) . Earlier experiments in rats (20, 29) (37) .
Diastolic left ventricular function has not been evaluated in previous fully published studies (19, (24) (25) (26) (27) (18, 25, 41) . In only one study was a significant increase in isometric muscle strength observed in one muscle group (hip flexion) (42) . In the present study there was no significant concomitant change in isometric muscle strength in any of five muscle groups (43) . Although it has been suggested that the muscle strength-testing methods employed may have not been suitable for this population (42) , the mechanism by which exercise tolerance improved remains uncertain.
No adverse effects of GH replacement on the cardiovascular system were seen. In particular, no increase in resting blood pressure was observed and there were no changes in cardiac rhythm.
We conclude that 6 
